CABA - Cabaletta Bio Inc Revenue Growth YoY (Last 12 Months)
The integration of ESG standards and bioethics into the development of cellular therapies reduces risks, establishing a foundation for protecting CAR-T patents and ensuring FDA compliance for Cabaletta Bio, Inc. (CABA). Year-over-year revenue dynamics over the last 12 months confirm this foundation, with the current level standing at 0.00. The picture is completed by a strategic focus on treating severe immune pathologies with the support of insurance companies.
&width=1200&height=400&colorIndex=0&v=mwhdatcg.m7-7dqbc3k&start=20220704&end=20261115&filename=GURU_Markets_-_CABA_-_Cabaletta-Bio-Inc._-_Sales-Growth-YoY-TTM "cabalettabio.com - CABA Sales Growth YoY (TTM) (period 02/11/2024 - 11/15/2026) | 👁️GURU.Markets👁️")
Summary analytical data breakdowns for Cabaletta Bio (CABA)
- market value and analyst target forecast:
- market capitalization statistics:
- shareholders' equity book value data:
- business debt structure and liquidity details:
Total Debt to Capital Cabaletta Bio, Inc.|CABA - Long-Term Debt to Equity|Short-Term Debt to Equity Cabaletta Bio|CABA - Company Aggregate Debts|Debts to Book Value Cabaletta Bio, Inc|CABA - Company Long-Term Liabilities|Amount of Current Liabilities Cabaletta Bio, Inc.|Intermediate Liquidity Ratio cabalettabio.com
- business earnings and investment ratios data:
CABA - Net Profit|Projected Future Earnings Cabaletta Bio, Inc.|CABA - Price to Earnings Ratio|Future Price to Earnings Multiple Cabaletta Bio, Inc.|CABA - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cabaletta Bio|CABA - Operating profit EBITDA|Net earnings per share for the last four quarters Cabaletta Bio, Inc.|CABA - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months cabalettabio.com|CABA - Net earnings per share growth this year|Expected earnings per share trend next year Cabaletta Bio, Inc.
- sales revenue and business income indicators:
Summary company analytics:Cabaletta Bio, Inc.
Cabaletta Bio, Inc. (CABA) specializes in developing innovative cell therapies for the treatment of severe autoimmune pathologies. The trailing twelve-month revenue dynamics allow for an assessment of the commercialization of its developments, capturing the vector of operational acceleration and the risk of a market cycle shift via the trailing 12-month sales growth rate compared to the previous year, which is critical for monitoring the financial stability of the biotech startup.
Competitor analysis for Cabaletta Bio, Inc.
Argenx (ARGX) - Trailing Twelve Months Revenue Growth|BioNTech SE - Sales Growth YoY (TTM)|ABVX - Sales Growth YoY (TTM)|ADMA: Sales Growth YoY (TTM)|Protagonist Therapeutics, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Immunovant Therapeutics|Sales Growth YoY (Last 12 Months) KNSA (Kiniksa Pharmaceuticals Ltd)|Sales Growth YoY (TTM) GRFS|ADPT: Trailing Twelve Months Sales Growth|Sales Growth YoY (TTM) CLDX (Celldex)|AUPH: Sales Growth YoY (Last 12 Months)|BCRX: Revenue Growth YoY (Last 12 Months)|Vera Pharma - Revenue Change YoY (Last 12 Months)|DNTH (Dianthus Corp) - Revenue Growth YoY (Last 12 Months)|Pharvaris N.V. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) AbCellera Biologics|Tourmaline Bio Inc (TRML) - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) PGEN (Intrexon)|PHAR (Pharming) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) NKTR (Nektar Therapeutics Inc)|Annual Revenue Growth (Last Twelve Months) upstreambio.com (UPB)|Zenas Biopharma - Sales Growth YoY (TTM)|IMNM (Immunome) - Sales Growth YoY (Last 12 Months)|gossamerbio.com (GOSS) - Sales Growth YoY (Last Twelve Months)|KalVista Corp (KALV) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) septerna.com|Sales Growth YoY (TTM) Pieris Pharmaceuticals|Sales Growth YoY (Last Twelve Months) Savara (SVRA)|RIGL - Trailing Twelve Months Revenue Growth|AnaptysBio Inc. - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (TTM) Astria Therapeutics ATXS|ENGN: Revenue Growth YoY (Last 12 Months)|RAPT Therapeutics Inc. (RAPT) - Revenue Growth YoY (Last 12 Months)|JBIO (Aerovate Therapeutics) - Revenue Growth YoY (Last 12 Months)|ACRS: Revenue Change YoY (Last 12 Months)|KYTX (Kyverna Therapeutics, Inc) - Sales Growth YoY (TTM)|Sales Growth YoY (Last 12 Months) TLSA (Tiziana Life Sciences PLC)|Revenue Growth YoY (Last 12 Months) VTYX (Ventyx Biosciences)|Annual Revenue Growth (Last Twelve Months) theratech.com|Sales Growth YoY (TTM) AVTX (Avalo Therapeutics, Inc.)|Sales Growth YoY (TTM) Eledon Pharmaceuticals Inc. ELDN|AGEN: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) CLYM (Climb Bio, Inc)|ZURA: Sales Growth YoY (TTM)|aTyr Pharma, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Adagene Inc.|IMA: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) STTK|Revenue Growth YoY (Last 12 Months) Equillium Bio EQ|Sales Growth YoY (Last Twelve Months) Connect Biopharma CNTB|IMUX - Revenue Growth YoY (Last 12 Months)|ATRA - Sales Growth YoY (Last Twelve Months)|InflaRx NV (IFRX) - Revenue Growth YoY (Last 12 Months)|XFOR (X4 Pharmaceuticals Inc.) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Adicet Bio Inc. (ACET)|Sales Growth YoY (Last Twelve Months) celularity.com|Revenue Growth YoY (Last 12 Months) inmunebio.com (INMB)|Sales Growth YoY (Last Twelve Months) Barinthus Biotherapeutics PLC (BRNS)|Annual Revenue Growth (Last Twelve Months) Kezar Life Sciences Inc.|SAB Biotherapeutics, Inc - Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) Akari Therapeutics, Plc (AKTX)|ENLV: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) QTTB (q32bio.com)|GeoVax Labs Inc (GOVX) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) Edesa|Sales Growth YoY (Last Twelve Months) iBio, Inc.|Revenue Growth YoY (Last 12 Months) carismatx.com (CARM)|Sales Growth YoY (TTM) XTLB|Revenue Growth YoY (Last 12 Months) Bolt Bio BOLT|Sales Growth YoY (TTM) HCWB (HCW Biologics)|APVO: Sales Growth YoY (Last 12 Months)|AIM - Sales Growth YoY (Last Twelve Months)|ADTX - Sales Growth YoY (TTM)|GRI Bio (GRI) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) XORTX Therapeutics|Sales Growth YoY (Last Twelve Months) Vyome Therapeutics|Sales Growth YoY (Last 12 Months) REVB (Revelation Biosciences, Inc.)|Sales Growth YoY (TTM) INDP|Revenue Growth YoY (Last 12 Months) Scinai Immunotherapeutics SCNI|Sales Growth YoY (TTM) CALI (CalciMedica)|AFMD - Revenue Growth YoY (Last 12 Months)|ALLK: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) HOOKIPA Pharma HOOK|IGMS: Sales Growth YoY (TTM)|ITOS: Revenue Change YoY (Last 12 Months)|Sales Growth YoY (Last Twelve Months) Ocean Biomedical|tcbiopharm.com - Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) Third Harmonic Bio, Inc. (THRD)
